Skip to main navigation Skip to search Skip to main content

Illimis Therapeutics Inc and Korea Advanced Institute of Science & Technology Submit WIPO Patent Application for ErbB4-targeting Composition for Preventing, Treating or Diagnosing Neurodegenerative Diseases

Press/Media

Period23 Oct 2025

Media coverage

1

Media coverage

  • TitleIllimis Therapeutics Inc and Korea Advanced Institute of Science & Technology Submit WIPO Patent Application for ErbB4-targeting Composition for Preventing, Treating or Diagnosing Neurodegenerative Diseases
    Media name/outletGLOPRM
    Country/TerritoryUnited States
    Date23/10/25
    PersonsYoung-Koo Lee
View all 1
View less